People with genetic cancer risk to help shape future of prevention in bold new study

Contributed by: Yorkshire Cancer Research

Logo

37-year-old Beth (far right) is the only one of her three sisters to carry a BRCA gene variant.

Images

Dr Stuart Griffiths, Director of Research, Policy and Impact at Yorkshire Cancer Research.

Beth Elias, a mother-of-two from Bradford and ambassador for the Yorkshire Cancer Research PARCC study.

Dr Stephanie Archer, Lead Investigator for the Yorkshire Cancer Research funded PARCC study.

Tags

Cancer

Genetic

More Like This

LYNPARZA (OLAPARIB) ACCEPTED FOR USE IN SCOTLAND TO TREAT GERMLINE BRCA-MUTATED HER2-NEGATIVE LOCALLY ADVANCED OR METASTATIC BREAST CANCER AFTER CHEMOTHERAPY

PR Newswire associated0

Discovery of cancer risk associations for six novel genes

NEW TESTS TO IDENTIFY HEREDITARY CANCER RISKS TO BE LAUNCHED

Veritas Genetic participates in a groundbreaking study highlighting the importance of polygenic risk scores in the clinical management of breast cancer patients

Yorkshire Cancer Research

Inequalities in ovarian cancer treatment revealed in new study

Linda Barker, Health Access Coordinator at Leeds GATE.

Gypsy, Traveller and Roma cancer study aims to address “long history of neglect”

After being diagnosed with brain cancer last year and facing limited treatment options in Yorkshire, 47-year-old mum-of-two Emma Ward from York is sharing her experience.

New life-giving clinical trials to be offered to people with most common type of brain cancer

Dr Stuart Griffiths, Director of Research, Policy and Impact at Yorkshire Cancer Research.

Yorkshire Cancer Research statement on the Government’s National Cancer Plan: A major opportunity to end regional inequalities